NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

Peptides

Method and composition for treating sarcopenia

PCSK9 VACCINE

MATERIALS AND METHODS FOR MODULATING IMMUNE RESPONSES

Glycotargeting therapeutics

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS

Immune tolerant and non-immune tolerant elastin-like recombinant peptides and methods of use

Conjugates of GM-CSF and IL-7, and Compositions Thereof

Peptide vaccines usable for hypercholesterolemia related diseases

OSTEOPONTIN AND THROMBIN-CLEAVED FRAGMENT THEREOF AND THEIR USE IN ATHEROSCLEROSIS PREVENTION, INFLAMMATION REDUCTION AND IMPROVING PLAQUE STABILITY

Neutralizing antibodies and methods of use thereof

Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered form

Modulation of proprotein convertase subtilisin/kexin 9 expression (PCSK9) with HSP 27 and/or HSP25

Multi-epitopic construct

DNA molecules encoding antibodies to tau and methods of making thereof

Thyroid stimulating hormone receptor peptides and uses thereof

RELAXIN1 derived peptides for use in immunotherapy against various tumors

Universal cancer vaccine

MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES

Peptides and combination of peptides for use in immunotherapy against various tumors

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

Methods for inducing partial apoptosis using caspase polypeptides

VISTA Agonist and Methods of Use

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Compositions and methods for modulating an immune response

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Complement component C5 antibodies

Concurrent Chemotherapy and Immunotherapy

IMMUNOTHERAPY WITH BINDING AGENTS

Modified yeast-brachyury immunotherapeutic compositions

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

METHOD AND VACCINE COMPRISING COPOLYMER 1 FOR TREATMENT OF PSYCHIATRIC DISORDERS

Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome

VACCINES FOR THE TREATMENT AND PREVENTION OF IGE MEDIATED DISEASES

Adjuvant for vaccines, vaccine, and immunity induction method

Combination therapies for the treatment of Alzheimer's disease and related disorders

Combination therapies for the treatment of Alzheimer's disease and related disorders

Combination therapies for the treatment of Alzheimer'S disease and related disorders

Vaccine Composition Containing Synthetic Adjuvant

Combination of vaccination and inhibition of the PD-1 pathway

Combination of vaccination and inhibition of the PD-1 pathway

Recombinant proteins and their therapeutic uses

Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies

Peptides and combination of peptides for use in immunotherapy against various tumors

T cell receptors recognizing MHC class II-restricted MAGE-A3

PLACENTAL VACCINATION THERAPY FOR CANCER

Fusion polypeptide for immuno-enhancement and method for enhancing stimulation of immune response using the same

IL-23-p19 vaccines

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

SMALL MOLECULE ENHANCER FOR DENDRITIC CELL CANCER VACCINES

Silicon dioxide nanoparticles and the use thereof for vaccination

Biodegradable lipids for the delivery of active agents

Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

Heterocyclic compounds and uses thereof

DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS

Peptides and combination of peptides for use in immunotherapy against various tumors

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Compositions and methods for enhancing an immune response

Molecular Antigen Array

Methods of treatment using an interferon gamma inhibitor

Peptides and combination of peptides for use in immunotherapy against various tumors

Compositions and methods for treating obesity and hyperphagia

METHOD FOR PREVENTION OF COLECTOMY

Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions

Method for allogeneic cell therapy

Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates

Gas-filled microvesicles for use as vaccine

Methods and compositions for enhancing an immune response, blocking monocyte migration, amplifying vaccine immunity and inhibiting tumor growth and metastasis

Methods and compositions relating to anti-CCR7 antigen binding proteins

Method for the treatment of idiopathic pulmonary fibrosis

Anti-IL-6 vaccine composition

CD4 T cells provide antibody access to immunoprivileged tissue

Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

MHC-I restricted epitopes containing non-natural amino acid residues

Peptides and combination of peptides for use in immunotherapy against various tumors

Modified virus-like particles of CMV

Nucleic acids encoding complement component C5 antibodies

Peptides and combination of peptides for use in immunotherapy against various tumors

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

CELL SENESCENCE MARKERS AS DIAGNOSTIC AND THERAPEUTIC TARGETS

GLYCOTARGETING THERAPEUTICS

Growth differentiation factor 15 (GDF-15) polypeptides

VASCULAR DISRUPTION AGENTS AND USES THEREOF

Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use

Oral administration of at least one pharmaceutical and/or antigenic active substance

FGF-23 epitope peptides and methods of use thereof

RECOMBINANT CHICKEN INTERLEUKIN-1 BETA PROTEIN FOR PRODUCING ANTIBODY EARLY AND RETAINING FOR A LONGER PERIOD OF TIME AND APPLICATION THEREOF

Method for regressing pancreatic tumor by a liposomal formulation along with DNA vaccines

Lipid vesicle compositions and methods of use

Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions

ANNEXIN A2 AS IMMUNOLOGICAL TARGET

Immunological treatment of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

Active agent delivery devices and methods of using the same

INNATE IMMUNE MODULATING MOLECULE COMPLEX FOR THE ACTIVATION OF THE INNATE IMMUNE SYSTEM OF AQUATIC ANIMALS AND METHODS THEREFOR

Pharmaceutical cyclosporin compositions

Universal cancer vaccine

Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3

VACCINE PHARMACEUTICAL COMPOSITION FOR SUPPRESSING APOPTOSIS OF CTL OR INHIBITING SUPPRESSION OF INDUCTION OF CTL

Therapeutic agent for cancer which comprises combination of IL-18 and molecule-targeting antibody

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

A COMBINATION OF KYNURENINE AND ANTIGEN PRESENTING CELLS (APC) AS THERAPEUTICS AND METHODS FOR THEIR USE IN IMMUNE MODULATION

Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For Immunotherapy

METHODS OF TREATING DIABETES AND COMPOSITIONS CAPABLE OF SAME

Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of parkinsons disease

Oral pharmaceutical composition

PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same

PD-L1 FUSION PROTEIN AND USE THEREOF

Recombinant Bacterium and Uses Thereof

DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION

GENE EDITED ANTIGEN PRESENTING CELLS

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Tannin-chitosan composites

VACCINES AND MONOCLONAL ANTIBODIES TARGETING TRUNCATED VARIANTS OF OSTEOPONTIN AND USES THEREOF

Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau

Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing

Use of Anti-MCAM Antibodies for Treatment or Prophylaxis of Giant Cell Arteritis, Polymyalgia Rheumatica or Takayasus Arteritis

PLACENTAL COMPOSITIONS FOR STIMULATION OF IMMUNITY TO PD-L1

ATTENUATED AND ADAPTED STRAIN OF PSEUDOMONAS FOR DELIVERING ANTIGENS

Allergy inhibitor compositions and kits and methods of using the same

Treatments using a peptide and/or vaccine

Methods of inhibiting platelet aggregation and preventing thrombosis using antibodies that bind (Na+K)-ATPase beta subunit

PCSK9 vaccine

Methods and compositions for treating Siglec-8 associated diseases

Peptide vaccines against PCSK9

Recombinant RNA particles and methods of producing proteins

Method for prevention of colectomy

Glycotargeting therapeutics

PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy

Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity

Activation of (NA+K)-ATPase inhibits platelet aggregation and prevents thrombosis

Peptide mimotopes of claudin 18.2 and uses thereof

Immunotherapy with binding agents

ANTIGEN-SPECIFIC IMMUNOTHERAPY USING TOLERIZING LIPOSOMES

VISTA antagonist and methods of use

Treatment of IL-17A diseases

Chimeric virus-like particles incorporating fusion GPI anchored GM-CSF and IL-4 conjugates

Multipartite signaling proteins and uses thereof

TOPK peptides and vaccines including the same

Small molecule enhancer for dendritic cell cancer vaccines

Methods of diagnosing tau-protein-associated disease

Silicon dioxide nanoparticles and the use thereof for vaccination

Method for treating amyloid disease

Lipid vesicle compositions and methods of use

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Diagnosis and treatment of autoimmune diseases

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Peptides and combination of peptides for use in immunotherapy against various tumors

Antibodies and fragments thereof raised against the alpha-3 domain of HLA-G protein, methods and means for their preparation, and uses thereof

Immunomodulators

T CELL RECEPTORS DIRECTED AGAINST THE PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA AND USES THEREOF

Mutant calreticulin for the diagnosis of myeloid malignancies

Uses of conjugates of GM-CSF and IL-7 to treat viral infections

Galectin-3 as immunological target

Glycotargeting therapeutics

Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

PLACENTAL COMPOSITIONS FOR STIMULATION OF IMMUNITY TO PD-L1

Particles with multiple functionalized surface domains

Oligomer-specific amyloid beta epitope and antibodies

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS

FasR antibodies and methods of use

CXCL12 (CHEMOKINE (C-X-C MOTIF) LIGAND 12) AND IGFBP2 INHIBITORS FOR THE APPLICATION IN THE TREATMENT OF DIABETES MELLITUS ASSOCIATED PANCREATIC CANCER

ANTI-GALECTIN-1 (GAL1) MONOCLONAL ANTIBODIES AND FRAGMENTS THEREOF FOR NEUTRALIZING GAL1

Mucosal vaccine composition

METHOD AND VACCINE COMPRISING COPOLYMER 1 FOR TREATMENT OF PSYCHIATRIC DISORDERS

EPITOPE VACCINE FOR LOW IMMUNOGENIC PROTEIN AND PREPARING METHOD AND USAGE THEREOF

Virus like particle comprising modified envelope protein E3

Peptides for enhancing transdermal delivery

Inotropic antibodies and therapeutic uses thereof

MUCOUS LAYER-ADHESIVE POLY-r-GLUTAMIC ACID NANOMICELLES AND DRUG DELIVERY SYSTEM USING SAME

Vaccine

Method to generate antibodies to ion channels

DPP-4-TARGETING VACCINE FOR TREATING DIABETES

Peptides

Methods and compositions for inhibiting diseases of the central nervous system

Compositions for and methods of treating and preventing targeting tumor associated carbohydrate antigens

Method of modulating the activity of adrenomedullin in a subject in need of therapeutic intervention for organ dysfunction or organ failure associated with adranomedullin (ADM) activity by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment to the subject

Method and composition for treating sarcopenia

PREVENTION OF TYPE 1 DIABETES BY TREG VACCINATION WITH AN INSULIN MIMETOPE

Human anti-SOD1 antibodies

Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders

Anti-galectin-1 monoclonal antibodies and fragments thereof

Mini-intronic plasmid DNA vaccines in combination with LAG3 blockade

Pharmaceutical cyclosporin compositions

Method for allogeneic cell therapy

Combination therapies for the treatment of Alzheimer's disease and related disorders

Combination therapies for the treatment of alzheimer's disease and related disorders

Methods and compositions related to immunogenic fibrils

Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins

Methods for inducing partial apoptosis using caspase polypeptides

CETP antigenic peptide and fusion protein and their composition and applications

Adjuvant compositions and related methods

Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases

DRY SOLID ALUMINUM ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF

Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent

CONJUGATED VACCINE

Combination of vaccination and inhibition of the PD-1 pathway

Gastrin peptide immunogenic composition

T cell receptors directed against Bob1 and uses thereof

Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins

VACCINE PEPTIDE COMBINATIONS AGAINST CAT ALLERGY

IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION

PCSK9 peptide combination vaccine and method of use

FUNCTIONAL GHRELIN RECEPTOR ANTAGONISM DURING PREGNANCY TO PREVENT STRESS-ASSOCIATED MENTAL ILLNESS IN OFFSPRING AND MOTHERS

Vaccine composition

Composition of Organic Compounds

Immunostimulatory compositions and methods of use thereof

Epidermal growth factor fusion proteins with mutant cholera toxin B subunits

Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein

VISTA Antagonist and Methods of Use

Methods and compositions related to immunogenic fibrils

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness

Methods for improving immunological response in vaccinated animals

METHODS OF TREATMENT USING AN INTERFERON GAMMA INHIBITOR

Virus like particle comprising modified envelope protein E3

METHOD

Immunogenic compositions for inducing an immune response for elimination of senescent cells

MAMMALIAN PROTEIN CO-RECOGNITION BY BROADLY NEUTRALIZING ANTIBODIES AS MODIFIED IMMUNOGENS FOR RE-ELICITATION

Compositions and methods for modulating an immune response

Compositions comprising hypoxia inducible factor-1 alpha and methods of using the same

Immunogenic composition in emulsion form

Vaccine delivery devices

MHC-I restricted epitopes containing non-natural amino acid residues

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES

Biodegradable lipids for the delivery of active agents

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

HER-1, HER-3 and IGF-1R compositions and uses thereof

Oral pharmaceutical composition

Vaccine for preventing porcine edema disease

PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDES

COMPOSITIONS EMPLOYING ALTERNATIVE READING FRAME POLYPEPTIDES FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASE

Compositions and methods using recombinant MHC molecules for the treatment of stroke

Disease therapy using a tolerogenic pharmaceutical preparation

Dose selection of adjuvanted synthetic nanocarriers

Nasal vaccine against the development of atherosclerosis disease and fatty liver

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR INDUCING REGULATORY B CELLS

Small cationic antimicrobial peptides

COMPOSITIONS AND METHODS FOR TREATING IMMUNE CONDITIONS, INCLUDING TYPE 1 DIABETES

MODIFIED FVIII APITOPE PEPTIDES

Vaccine capable of inducing formation of antibodies directed to proprotein convertase subtilisin/kexin type 9 (PCSK9) in vivo

PEPTIDE INHIBITORS FOR MEDIATING STRESS RESPONSES

Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant

Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness

Combination of local and systemic immunomodulative therapies for melanoma and liver cancer

Heterocyclic compounds and uses thereof

Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

Semi-solid delivery systems

Induction of antigen-specific tolerance by peripheral phagocytosis

Combination therapies for the treatment of Alzheimer's disease and related disorders

Methods to enhance T-cell mediated immune response

Regulatory T cell epitope and hepatitis C virus homolog

Multipartite signaling proteins and uses thereof

Vaccine for treatment of tautopathy

Peptide for reducing the phosphate requirement and excretion from farm animals

VACCINE COMPOSITIONS AND METHODS OF USE

Method for Eliciting an Immune Response to Human Telomerase Reverse Transcriptase

T cell receptors recognizing MHC class II-restricted MAGE-A3

NON-DIGESTIBLE OLIGOSACCHARIDES FOR ORAL INDUCTION OF TOLERANCE AGAINST DIETARY PROTEINS

Complement component C5 antibodies

Compositions and Methods for Delivery of Antigens to Plasmacytoid Dendritic Cells

Compounds and methods for targeted immune system delivery

Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing

Immunogenic compositions comprising progastrin and uses thereof

VISTA Antagonist and Methods of Use

Silicon dioxide nanoparticles and the use thereof for vaccination

BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE

IMMUNOMODULATORY AGENT AND USES THEREFOR

Methods and compositions for treating multiple sclerosis and related disorders

Peptide conjugated particles for the treatment of allergy

Compounds and methods for modulating pharmacokinetics

IgE peptide vaccine

Methods and compositions for enhancing vaccine immune responses

Compositions and methods for modulating TLR4

Immunoregulatory vaccine

Modulation of yeast-based immunotherapy products and responses

Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome

Treatment of IgE-mediated disease

Compounds and methods for the detection of TRPV-6 cancers and drug delivery

Methods and compositions for enhancing an immune response, blocking monocyte migration, amplifying vaccine immunity and inhibiting tumor growth and metastasis

Isoindolin-1-ones as macrophage migration inhibitory factor (MIF) inhibitors

MODIFICATION OF THE IMMUNOMODULATORY EFFECTS OF CELLS

Method of inhibiting C5a

NON-NATURAL MIC PROTEINS

Method for treating amyloid disease